Psoriasis can cause patients to have an increased risk of cardiovascular disease, including hypertension. Many psoriasis patients being treated for hypertension have had adverse reactions to the antihypertensive drugs, causing their psoriasis to return. In some patients without known psoriasis, hypertension medications even brought about new instances of psoriasis. In this paper, we review the literature describing cases of reactions (mainly negative] in psoriasis patients taking antihypertensive medications. We examine different classes of hypertension medications, including ACE inhibitors, beta-blockers, and calcium channel blockers. Since there have been so many reported incidents, physicians using antihypertensive drugs for patients with psoriasis should consider the implications of using each type of drug, and should use this information to prescribe a less-reactive drug type if possible.
ArmstrongA.W., LinS.W., ChambersC.J., SockolovM.E., ChinD.L.Psoriasis and Hypertension Severity: Results from a Case-Control Study. PLoS ONE.2011; 6(3): e18227.
5.
HamletN.W., KeefeM., KerrR.E.I.Does captopril exacerbate psoriasis?Br Med J (Clinical Research Edition).1987; 295(6609): 1352.
6.
WolfR., TamirA., BrennerS.Psoriasis related to angiotensin-converting enzyme inhibitors. Dermatologica.1990; 181(1): 51–3.
7.
ThakorP., PadmanabhanM., JohnsonA., PararajasingamT., ThakorS., JorgensenW.Ramipril-Induced Generalized Pustular Psoriasis: Case Report and Literature Review. Am J Ther.2010; 17(1): 92–5.
Marquart-ElbazC., GrosshansE., LipskerD., LipskerD.Sartans, angiotensin II receptor antagonists, can induce psoriasis. Br J Dermatol.2002; 147(3): 617–8.
13.
TsankovN., AngelovaI., KazandjievaJ.Drug-induced psoriasis. Recognition and management. Am J Clin Dermatol.2000; 1(3): 159–65.
14.
GoldM.H., HolyA.K., RoenigkH.H.Beta-blocking drugs and psoriasis. A review of cutaneous side effects and retrospective analysis of their effects on psoriasis. J Am Acad Dermatol.1988; 19(5): 837–41.
15.
YilmazM., TurhanH., AkinY., KisacikH., KorkmazS.Beta-blocker-induced psoriasis: a rare side effect—a case report. Angiology.2002; 53(6): 737–9.
16.
WaqarS., SarkarP.K.Exacerbation of psoriasis with beta-blocker therapy. CMAJ.2009; 181(1-2): 60
17.
BasavarajK.H., AshokN.M., RashmiR., PraveenT.K.The role of drugs in the induction and/or exacerbation of psoriasis. Int J Dermatol.2010; 49(12): 1351–61.
18.
BrauchliY.B., JickS.S., CurtinF., MeierC.R.Association Between Beta-Blockers, Other Antihypertensive Drugs and Psoriasis: Population-based Case-control Study. Br J Dermatol.2008; 158(6): 1299–1307.
19.
CohenA.D., KagenM., FrigerM., HalevyS.Calcium Channel Blockers Intake and Psoriasis: A Case-control Study. Acta Derm Venereol.2001; 81: 347–9.
20.
KitamuraK., KanasashiM., SugaC., SaitoS., YoshidaS., IkezawaZ.Cutaneous Reactions Induced by Calcium Channel Blocker: High Frequency of Psoriasiform Eruptions. J Dermatol.1993; 20(5): 279–86.
21.
IouliosP., CharalamposM., EfrossiniT.The spectrum of cutaneous reactions associated with calcium antagonists: a review of the literature and the possible etiopathogenic mechanisms. Dermatol Online J.2003; 9(5): 6.
22.
RamanG.V., CampbellS.K., FarrerA.Modifying effects of amlodipine on cyclosporin A-induced changes in renal function in patients with psoriasis. J Hypertens Suppl.1998; 16(4): S39–41.
WolfR., DorfmanB., KrakowskiA.Psoriasiform eruption induced by captopril and chlorthalidone. Cutis.1987; 40(2): 162–4.
25.
HöcherlK., KeesF., KrämerB.K., KurtzA.Cyclosporine A attenuates the natriuretic action of loop diuretics by inhibition of renal COX-2 expression. Kidney Int.2004; 65(6): 2071–80.
